Francis Man Selected Research

doxofylline

4/2014

Doxofylline, a novofylline inhibits lung inflammation induced by lipopolysacharide in the mouse.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Francis Man Research Topics

Disease

7	Neoplasms (Cancer) 01/2023 - 01/2018
3	Pneumonia (Pneumonitis) 11/2021 - 04/2014
3	Inflammation (Inflammations) 11/2021 - 04/2014
2	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2018
2	Melanoma (Melanoma, Malignant) 01/2023 - 01/2021
2	Breast Neoplasms (Breast Cancer) 12/2021 - 01/2019
1	Hematologic Neoplasms (Hematological Malignancy) 10/2020
1	Eosinophilia 01/2020
1	Asthma (Bronchial Asthma) 01/2020
1	Tuberculosis (Tuberculoses) 01/2020
1	Respiratory Tract Diseases (Respiratory Tract Disease) 04/2014

Drug/Important Bio-Agent (IBA)

2	Immunoglobulin E (IgE)IBA 01/2023 - 01/2021
2	chondroitin sulfate proteoglycan 4IBA 01/2023 - 01/2021
2	AntigensIBA 01/2023 - 01/2021
2	Radioisotopes (Radionuclides)IBA 12/2021 - 01/2018
2	sodium-iodide symporter (sodium iodide symporter)IBA 12/2021 - 10/2020
2	IRL201104IBA 11/2021 - 01/2020
2	Peptides (Polypeptides)IBA 11/2021 - 01/2020
2	ChaperoninsIBA 11/2021 - 01/2020
1	Fc Receptors (Fc Receptor)IBA 01/2023
1	Cytarabine (Cytosar-U)FDA LinkGeneric 12/2021
1	CytokinesIBA 12/2021
1	Green Fluorescent ProteinsIBA 12/2021
1	Peptide FragmentsIBA 11/2021
1	Proteins (Proteins, Gene)FDA Link 11/2021
1	Immunoglobulin G (IgG)IBA 01/2021
1	AntibodiesIBA 01/2021
1	Chimeric Antigen ReceptorsIBA 10/2020
1	OvalbuminIBA 01/2020
1	Alendronate (Alendronate Sodium)FDA LinkGeneric 01/2019
1	Liposomes (Liposome)IBA 01/2019
1	doxofyllineIBA 04/2014
1	XanthineIBA 04/2014
1	Bronchodilator Agents (Bronchodilators)IBA 04/2014

Therapy/Procedure

4	Therapeutics 01/2023 - 10/2018
2	Immunotherapy 01/2023 - 12/2021
1	Intravenous Administration 01/2021